Cullinan therapeutics announces preclinical data for cln-978, a cd19-directed t cell engager, to be presented at acr convergence 2024

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of cln-978 in autoimmune diseases

CGEM Ratings Summary

CGEM Quant Ranking